This grant will fund collaborative pilot studies using advanced microphysiological systems to model type 2 diabetes, aiming to improve understanding and treatment through innovative in vitro research approaches.
Funder: National Institutes of Health
Due Dates: July 5, 2026 (estimated)
Funding Amounts: Estimated total program funding: $1,000,000; ~4 awards expected; pilot study scale
Summary: Supports collaborative pilot studies using microphysiological systems to model type 2 diabetes and generate preliminary data for future research.
Key Information: Forecasted opportunity—applications not yet open; start planning collaborations now.
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) intends to launch a funding opportunity to support collaborative pilot research using microphysiological systems (MPSs) to model type 2 diabetes (T2D). This initiative aims to advance the use of biomaterials, microfluidics, and tissue engineering to create sophisticated in vitro models that better mimic human metabolic tissues and their interactions. These systems will enable researchers to investigate the heterogeneity of human T2D, study disease mechanisms, and test prevention or treatment strategies. The opportunity is designed to fund small-scale, collaborative feasibility or conceptual studies that generate preliminary data for future, larger projects. Applications are not being accepted at this time; this is an advance notice to allow researchers to build collaborations and develop responsive projects.